Apolipoprotein E ε4 allele and familial aggregation of Alzheimer disease

Archives of Neurology

Volumn 55, Issue 6, 1998, Pages 810-816

  Martinez, Maria ^a   Campion, Dominique ^d   Brice, Alexis ^b   Hannequin, Didier ^e   Dubois, Bruno ^b   Didierjean, Olivier ^b   Michon, Agnès ^b   Thomas Anterion, Catherine ^f   Puel, Michèle ^g   Frebourg, Thierry ^e   Agid, Yves ^b   Clerget Darpoux, Françoise ^c  

^a SAINT LOUIS HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d CHS du Rouvray   (France)

^e ROUEN UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^g CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; FAMILY; FEMALE; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; UNIVERSITY HOSPITAL; AGED; FORECASTING; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PEDIGREE; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; RISK FACTORS;

EID: 0031596373     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.6.810     Document Type: Article

References (35)

1. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
2. van Duijn CM, Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994;7:74-78.
3. Pérez-Tur J, Campion D, Martinez M, et al. Evidence for apolipoprotein E ∈4 association in early-onset Alzheimer's patients with late-onset relatives. Am J Med Genet. 1995;60:550-553.
4. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
5. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, et al. Dose-dependent association of apolipoprotein E allele ∈4 with late-onset, sporadic Alzheimer's disease. Ann Neurol. 1994;36:656-659.
6. Jarvik GP, Larson EB, Goddard K, Kukull WA, Schellenberg GD, Wijsman EM. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet. 1996;58:191-200
7. Myers RH, Schaeffer EJ, Wilson PWF, et al. Apolipoprotein E4 association with dementia in a population based study: the Framingham study. Neurology. 1996; 46:673-677.
8. Bickeböller H, Campion D, Brice A, et al. ApoE and Alzheimer's disease: age, sex and genotype specific relative risks and incidence rates. Am J Hum Genet. 1997; 60:439-446.
9. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol. 1993;34:752-754.
10. Dai XY, Nanko S, Hattori M, et al. Association of apolipoprotein ∈4 with sporadic Alzheimer's disease is more pronounced in early-onset type. Neurosci Lett. 1994; 175:74-76.
11. Tang MX, Maestre G, Tsai WY, et al. Relative risk of Alzheimer's disease and age-at-onset distributions, based on apoE genotypes among elderly African Americans, caucasians, and Hispanics in New York City. Am J Hum Genet. 1996;58:574-584.
12. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipo-protein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697-699.
13. Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet. 1994;54:643-649.
14. Corder EH, Saunders AM, Strittmatter WJ, et al. The apolipoprotein E e4 allele and sex-specific risk of Alzheimer's disease. JAMA. 1995;273:373-374.
15. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer's disease: a possible clue to higher incidence of Alzheimer disease in women. Am J Hum Genet. 1996;58:803-811.
16. Rao VS, Cupples A, van Duijn CM, et al. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E ∈4. Am J Hum Genet. 1996;59:664-675.
17. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology. 1997;48:139-147.
18. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E ∈4 allele and the lifetime risk of Alzheimer's disease. Arch Neurol. 1995;52:1074-1079.
19. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol. 1996;40:55-66.
20. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction of Alzheimer's disease. Ann Neurol. 1995;38:6-14.
21. McKahnn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology. 1984;34:939-944.
22. Martinez M, Campion D, Babron MC, et al. Segregation analysis of French Alzheimer pedigrees: dominant inheritance at a major gene explains a minority of cases only. Am J Med Genet. 1996;67:9-12.
23. Campion D, Flaman JM, Brice A, et al. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet. 1995;4:2373-2377.
24. Campion D, Brice A, Hannequin D, et al. No founder effect in three novel Alzheimer's disease families with APP 717 Val→lle mutation. J Med Genet. 1996;33:661-664.
25. Farrer LA, Cupples A, van Duijn CM, et al. Apolipoprotein E genotype patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol. 1995;38:797-808.
26. Hixson JE, Vernier DT. Restriction isotyping of human apoE by gene amplification and cleavage with Hhal. Lipid Res. 1990;31:545-548.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
28. Benedetti J, Yuen K, Young L. Life tables and survival functions. In: Dixon WJ, ed. BMDP Statistical Software. Berkeley: University of California Press; 1985:557-575.
29. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphisms in healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993;39:2125-2129.
30. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. ApoE E allele frequencies in younger (age 42-50) vs older (age 65-90) women. Genet Epidemiol. 1993; 10:27-34.
31. Li G, Silverman JM, Altstiel LD, et al. Apolipoprotein E-∈4 allele and familial risk in Alzheimer's disease. Genet Epidemiol. 1996;13:285-298.
32. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, Morris JC. Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology. 1996;47:254-255.
33. Duara R, Lopez-Alberola RF, Barker WW, et al. A comparison of familial and sporadic Alzheimer's disease. Neurology. 1993;43:1377-1383.
34. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995;45:1323-1328.
35. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429-432.